Abstract

Amyloid deposition of the microtubule-associated protein tau is associated with neurodegenerative diseases. In frontotemporal dementia with abnormal tau (FTD-tau), missense mutations in tau enhance its aggregation propensity. Here we describe the structural mechanism for how an FTD-tau S320F mutation drives spontaneous aggregation, integrating data from in vitro, in silico and cellular experiments. We find that S320F stabilizes a local hydrophobic cluster which allosterically exposes the 306VQIVYK311 amyloid motif; identify a suppressor mutation that destabilizes S320F-based hydrophobic clustering reversing the phenotype in vitro and in cells; and computationally engineer spontaneously aggregating tau sequences through optimizing nonpolar clusters surrounding the S320 position. We uncover a mechanism for regulating tau aggregation which balances local nonpolar contacts with long-range interactions that sequester amyloid motifs. Understanding this process may permit control of tau aggregation into structural polymorphs to aid the design of reagents targeting disease-specific tau conformations.

The authors used multi-disciplinary approaches to understand the structural mechanism underlying spontaneous aggregation of tau encoding an S320F FTD-tau mutant. Understanding the mechanisms of tau aggregation will help identify novel methods to regulate its misfolding.

Details

Title
FTD-tau S320F mutation stabilizes local structure and allosterically promotes amyloid motif-dependent aggregation
Author
Chen, Dailu 1 ; Bali, Sofia 1   VIAFID ORCID Logo  ; Singh, Ruhar 2 ; Wosztyl, Aleksandra 2   VIAFID ORCID Logo  ; Mullapudi, Vishruth 2   VIAFID ORCID Logo  ; Vaquer-Alicea, Jaime 2 ; Jayan, Parvathy 2 ; Melhem, Shamiram 3 ; Seelaar, Harro 3   VIAFID ORCID Logo  ; van Swieten, John C. 3 ; Diamond, Marc I. 2   VIAFID ORCID Logo  ; Joachimiak, Lukasz A. 4   VIAFID ORCID Logo 

 University of Texas Southwestern Medical Center, Molecular Biophysics Graduate Program, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); University of Texas Southwestern Medical Center, Center for Alzheimer’s and Neurodegenerative Diseases, Peter O’Donnell Jr. Brain Institute, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 University of Texas Southwestern Medical Center, Center for Alzheimer’s and Neurodegenerative Diseases, Peter O’Donnell Jr. Brain Institute, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 Erasmus Medical Center, Department of Neurology & Alzheimer Center, Rotterdam, Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
 University of Texas Southwestern Medical Center, Center for Alzheimer’s and Neurodegenerative Diseases, Peter O’Donnell Jr. Brain Institute, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121); University of Texas Southwestern Medical Center, Department of Biochemistry, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
Pages
1625
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2789892609
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.